About Biodesix, Inc. Common Stock
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Market Cap
$0.11B
Employees
273
Listed Since
October 28, 2020
Industry
SERVICES-MEDICAL LABORATORIES
Website
www.biodesix.comPhone
303-417-0500
Headquarters
919 WEST DILLON ROAD
LOUISVILLE, CO 80027
CIK
0001439725